The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Workman, R. H.
* Articles by Kunik, M. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Workman, R. H., Jr
* Articles by Kunik, M. E.

J Neuropsychiatry Clin Neurosci 1997; 9:594-597
Copyright © 1997 by American Neuropsychiatric Association

REGULAR ARTICLES

The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease

RH Workman Jr, CA Orengo, AA Bakey, VA Molinari and ME Kunik
Veterans Affairs Medical Center, Houston, Texas 77030, USA. workman.richard_h_jr@houston.va.gov

This pilot study investigated effectiveness and tolerability of risperidone for the treatment of psychosis and agitation in 9 inpatients with Parkinson's disease and dementia. Investigators found risperidone to be effective and safe, without worsening extrapyramidal symptoms or further impairing cognition.




Get information about faster international access.

Privacy Policy

Copyright © 1997 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org